Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $277,000 - $313,900
-10,000 Reduced 33.33%
20,000 $578,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $776,700 - $891,900
30,000 New
30,000 $832,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $364,812 - $422,079
10,100 New
10,100 $370,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $981,250 - $1.26 Million
25,000 New
25,000 $1.08 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $1.55 Million - $1.97 Million
-46,300 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $1.88 Million - $2.2 Million
-59,100 Reduced 56.07%
46,300 $1.7 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $3.17 Million - $3.85 Million
105,400 New
105,400 $3.45 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.